Edap Tms (NASDAQ:EDAP) Receives "Hold" Rating from Jefferies Financial Group

Jefferies Financial Group reiterated their hold rating on shares of Edap Tms (NASDAQ:EDAP - Free Report) in a research report released on Friday morning, MarketBeat.com reports. They currently have a $2.00 target price on the medical equipment provider's stock, down from their previous target price of $8.00.

Several other brokerages also recently weighed in on EDAP. Piper Sandler dropped their target price on shares of Edap Tms from $5.00 to $4.50 and set an "overweight" rating for the company in a report on Friday, March 28th. HC Wainwright reaffirmed a "buy" rating and issued a $19.00 price objective on shares of Edap Tms in a research note on Friday, March 28th. Finally, StockNews.com started coverage on Edap Tms in a research note on Friday, March 28th. They set a "hold" rating on the stock.

Edap Tms Stock Performance

NASDAQ:EDAP traded up $0.03 during mid-day trading on Friday, hitting $1.48. 16,681 shares of the company traded hands, compared to its average volume of 92,058. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The stock's fifty day moving average price is $2.34 and its 200-day moving average price is $2.42. The firm has a market cap of $54.91 million, a price-to-earnings ratio of -2.28 and a beta of 0.12. Edap Tms has a one year low of $1.40 and a one year high of $8.50.

Remove Ads

Edap Tms (NASDAQ:EDAP - Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The company had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Research analysts anticipate that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

Several hedge funds have recently modified their holdings of EDAP. Illumine Investment Management LLC purchased a new stake in Edap Tms during the fourth quarter valued at approximately $50,000. BNP Paribas Financial Markets raised its holdings in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock valued at $59,000 after buying an additional 4,400 shares during the period. Jane Street Group LLC lifted its position in Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock worth $69,000 after buying an additional 73,361 shares during the last quarter. Millennium Management LLC boosted its stake in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after buying an additional 33,558 shares during the period. Finally, Orion Capital Management LLC increased its position in Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider's stock valued at $178,000 after acquiring an additional 6,600 shares during the last quarter. 62.74% of the stock is owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.